Intralesional injection of triamcinolone acetonide for subcutaneous lipoma causing musculoskeletal and neurologic symptoms

William A. Hayward, Wilme R.L. Sibbitt, Randy R. Sibbitt, Maheswari Muruganandam, Noelle A. Rolle, Monthida Fangtham, N. Suzanne Emil, Scarlett K. Kettwich

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Objective: Benign subcutaneous lipomas can cause musculoskeletal pain and nerve impingement. We hypothesized that the potent lipolytic and atrophic effect of 40mg/mL triamcinolone acetonide would atrophy symptomatic lipomas so surgical excision could be avoided. Design: This was a cohort study. Setting: This study took place in an ultrasound injection clinic. Participants: Eight subjects with painful symptomatic lipoma were included. Measurements: Preprocedurally, the margins of the lipomas were palpated and marked with ink, then measured in centimeters (cm). Small lipomas (1-3cm) were injected with 40mg triamcinolone acetonide, while large lipomas (4-6cm) were injected with 80mg of triamcinolone acetonide. The subjects were reassessed at a four-month follow-up appointment and then again at one year and two years after the procedure. Results: Preinjection, all eight subjects had symptoms related to impingement or pain with compression of the lipoma. At four months post-injection, none of the patients had symptoms attributable to the lipoma (p<0.001). The mean lipoma palpable dimension was 5.0±1.2cm prior to the injection and was 2.0±1.1cm at four months after the injection, with a significant mean 3.0±0.3cm (60%) reduction in lipoma dimensions (p<0.001). Two subjects demonstrated some mild hypopigmentation of the skin at four months post-injection. Within two years, three lipomas had symptomatically recurred, one of which was removed surgically and the two of which were reinjected. There were no infections or other serious adverse reactions that occurred. Conclusions: For individuals with painful subcutaneous lipoma, intralesional injection of 40mg/mL of triamcinolone acetonide is an effective and safe alternative to surgical excision or injection of sclerosing agents and should be considered as a reasonable therapeutic alternative in select patients.

Original languageEnglish (US)
Pages (from-to)38-42
Number of pages5
JournalJournal of Clinical and Aesthetic Dermatology
Issue number5
StatePublished - May 2018
Externally publishedYes


  • Corticosteroids
  • Injection
  • Lipoma
  • Musculoskeletal
  • Neurologic

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Intralesional injection of triamcinolone acetonide for subcutaneous lipoma causing musculoskeletal and neurologic symptoms'. Together they form a unique fingerprint.

Cite this